NKT Cells Co-Expressing a GD2-Specific Chimeric Antigen Receptor and IL-15 Show Enhancedin Vivopersistence and Antitumor Activity Against Neuroblastoma

被引：0
|
作者：
Xu, Xin [1 ]
Huang, Wei [1 ]
Heczey, Andras [2 ]
Liu, Daofeng [1 ]
Guo, Linjie [1 ]
Wood, Micheal [1 ]
Jin, Jinglin [1 ]
Courtney, Amy [1 ]
Liu, Bin [1 ]
DiPiero, Erica [1 ]
Hicks, John [1 ]
Barragan, Gabriel [1 ]
Savoldo, Barbara [3 ]
Dotti, Gianpietro [3 ]
Metelitsa, Leonid [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
[2] Baylor Coll Med, Sect Hematol & Oncol, Pediat, Houston, TX 77030 USA
[3] Univ N Carolina, Chapel Hill, NC 27515 USA
来源：
MOLECULAR THERAPY | 2019年 / 27卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
367
引用
收藏
页码：174 / 174
页数：1
相关论文
共 50 条
  • [41] γc Cytokines IL7 and IL15 Expanded Chimeric Antigen Receptor-Redirected T Cells (CAR-T) with Superior Antitumor Activity In Vivo
    Xu, Yang
    Zhang, Ming
    Mahendravada, Aruna
    Savoldo, Barbara
    Dotti, Gianpietro
    MOLECULAR THERAPY, 2013, 21 : S20 - S21
  • [42] Increased frequency of IL-7 and IL-15 receptor alpha chain (CD127, CD215) co-expressing CD4+T cells in granulomatosis with polyangiitis (Wegener's)
    Klapa, S.
    Schueler, S.
    Pitann, S.
    Klenerman, P.
    Gross, W. L.
    Lamprecht, P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (01) : S171 - S171
  • [43] Significant Targeting of Neuroblastoma By Anti-ROR1 Chimeric Antigen Receptor (CAR) Engineered NK Cells with or without IL-15 Superagonist (N-803) in Vitro and In Vivo Using Human Neuroblastoma Xenografted NSG Mice
    Chu, Yaya
    Nayyar, Gaurav
    Wong, Hing C.
    Seeger, Robert C.
    Lee, John H.
    Riddell, Stanley R.
    Safrit, Jeffrey
    Lee, Dean
    Cairo, Mitchell S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S256 - S256
  • [44] CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
    J Chu
    Y Deng
    D M Benson
    S He
    T Hughes
    J Zhang
    Y Peng
    H Mao
    L Yi
    K Ghoshal
    X He
    S M Devine
    X Zhang
    M A Caligiuri
    C C Hofmeister
    J Yu
    Leukemia, 2014, 28 : 917 - 927
  • [45] CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
    Chu, J.
    Deng, Y.
    Benson, D. M.
    He, S.
    Hughes, T.
    Zhang, J.
    Peng, Y.
    Mao, H.
    Yi, L.
    Ghoshal, K.
    He, X.
    Devine, S. M.
    Zhang, X.
    Caligiuri, M. A.
    Hofmeister, C. C.
    Yu, J.
    LEUKEMIA, 2014, 28 (04) : 917 - 927
  • [46] Constitutive expression of a chimeric receptor that delivers IL-2/IL-15 signals allows antigen-independent proliferation of CD8+CD44high but not other T cells
    Gasser, S
    Corthésy, P
    Beerman, F
    MacDonald, HR
    Nabholz, M
    JOURNAL OF IMMUNOLOGY, 2000, 164 (11): : 5659 - 5667
  • [47] Natural Killer T Cells Expressing a GD2-CAR and IL-15 Are Safe and Can Induce Complete Remission in Children with Relapsed Neuroblastoma - A First-in-Human, Phase 1 Trial
    Heczey, Andras
    Courtney, Amy
    Liu, Ka
    Li, Migmei
    Ghatwai, Nisha
    Dakhova, Olga
    Xu, Xin
    Ngai, Ho
    Di Piero, Erica
    Sher, Andrew
    Savoldo, Barbara
    Dotti, Gianpietro
    Metelitsa, Leonid
    MOLECULAR THERAPY, 2021, 29 (04) : 102 - 103
  • [48] Enhanced anti-tumor activity mediated by combination chimeric antigen receptor T cells targeting GD2 and GPC2 in high-risk neuroblastoma
    Wu, Huantong
    Zhang, Guangji
    Liu, Zhongfeng
    Liu, Weihua
    Wang, Xuan
    Zhao, Yu
    CYTOTHERAPY, 2024, 26 (11) : 1308 - 1319
  • [49] THERAPEUTIC EFFECTS OF ALT-803, AN IL-15 SUPERAGONIST, IN COMBINATION WITH ANTI-CD20 CHIMERIC ANTIGEN RECEPTOR MODIFIED EXPANDED NATURAL KILLER CELLS AGAINST BURKITT LYMPHOMA (BL)
    Chu, Y.
    Lee, F.
    Ayello, J.
    Hang, B.
    Zhang, M.
    Wong, H.
    Lee, D.
    Cairo, M.
    CYTOTHERAPY, 2016, 18 (06) : S59 - S59
  • [50] Therapeutic Effects of ALT-803, an IL-15 Superagonist, in Combination with Anti-CD20 Chimeric Antigen Receptor Modified Expanded Natural Killer Cells Against Burkitt Lymphoma (BL)
    Chu, Yaya
    Lee, Fangyu
    Ayello, Janet
    Hang, Brian
    Zhang, Melanie
    Wong, Hing C.
    Lee, Dean
    Cairo, Mitchell S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (03) : S151 - S151
12345